JESSICA GLIDEWELL: Open Payments
NPI 1639689656 · NEW ALBANY, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$967 in 43 payments from 20 companies in 2025. Trend: 2023 $2,267 · 2024 $2,793 · 2025 $967
Food & beverage: $874Education: $93
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $131 |
| E.R. Squibb & Sons, L.L.C. | 6 | $107 |
| Janssen Biotech, Inc. | 4 | $95 |
| Novartis Pharmaceuticals Corporation | 5 | $88 |
| Daiichi Sankyo Inc. | 3 | $77 |
| TerSera Therapeutics LLC | 2 | $53 |
| SpringWorks Therapeutics, Inc. | 2 | $53 |
| ABBVIE INC. | 3 | $51 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| PFIZER INC. | 2 | $41 |
Products named: KISQALI, Enhertu, ERLEADA, Xermelo, OGSIVEO, OPDIVO, JEMPERLI, TECVAYLI.
Industry payments across MS — which companies pay providers there.
